Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel
Successful epilepsy treatment found for rats
Study could help develop the treatment of epilepsy in others

UK researchers believe they have found a cure for epilepsy in rats by adding ‘calm down’ genes to hyperactive brain cells. They believe their approach could help people who cannot control their epileptic seizures with drugs.

Epilepsy is triggered by the rapid movement of neurons in the brain. These neurons are primed to fire off new messages; however, if a group of neurons become too excited they can throw the whole system into chaos leading to an epileptic seizure.

In order to test their hypothesis, researchers used a virus to insert the new genes into a small number of neurons. There are two methods to this; both use viruses injected into the brain to add tiny sections of DNA to the genetic code of just a few thousand neurons. One method boosts the brain cells' natural levels of inhibition in order to calm them down.

This treatment is a form of gene therapy, a field which is often criticised for failing to deliver. Early trials had problems with patients developing leukaemia and in one case a teenager died. One of the issues included the risk of inserting a new piece of DNA into the genetic code as it could disrupt other genes. There were also concerns about the safety of the virus.

Much more testing of the epilepsy gene therapies would be needed before it could be used in patients. If further animal tests are successful the first patients involved in any trial are likely to be those who are suitable and prepared for brain surgery. If there were problems or if the treatment did not work, the offending region of the brain could still be removed.

The chief executive of Epilepsy Action, Philip Lee, said: "Gene therapy research is an important development in our understanding of epilepsy. It is very encouraging that progress is being made in this arena to help people with epilepsy.

"Although it is too early to say if this research will directly benefit people with epilepsy in the future, we hope it helps us to move closer to more effective treatments."


Become a member or log in to add this story to your CPD history

Animal Medicines Amnesty returns this November

News Story 1
 Veterinary practices are being urged to help owners safely dispose of any unused and expired pet medicines - not just antibiotics - during November's Animal Medicines Amnesty.

Organised by the Responsible Use of Medicines Alliance Companion Animal and Equine (RUMA CA&E), the initative is supported by a range of cross-sector organisations.

Practices are encouraged to use the campaign to engage the whole practice team and raise awareness of the safe disposal of medicines with clients. Learn how your practice can get involved at rumacae.org.uk 

Click here for more...
News Shorts
Bluetongue RZ extended across Scotland

The Scottish Government has announced an extension to a Bluetongue Restricted Zone that is in place in south-west Scotland.

From 3 October, the Restricted Zone will be extended to cover the whole of Scotland. The Animal, Plant and Health Agency (APHA) says this is in response to further disease spread, as well as simplify trading conditions ahead of the autumn.

Since the whole country will share a disease status, it will no longer be necessary to have a movement license to move susceptible livestock around the country. Restrictions on germinal products remain.

As of 1 October 2026, there were 1,979 cases of BTV-3 in England, 389 cases in Wales and 40 cases in Scotland.